Istradefylline 40 mg/working day improved peak levels and AUC of CYP3A4 substrates in clinical trials. This effect wasn't observed with istradefylline twenty mg/day. Consider dose reduction of delicate CYP3A4 substrates.Coadministration with CYP3A4 substrates, particularly People with a slim therapeutic index, can result in diminished concentration